Onyvax Company
Onyvax develops cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells.
Funding Status:
Late Stage Venture
Investors Number:
5
Employee Number:
11-50
Last Funding Date:
2006-05-08
Headquarters:
Bradford, Somerset, United Kingdom
Last Funding Type:
Series C
Total Funding:
29810445
Founded Date:
1997-01-01
Industry:
Whole-Cell Antigens